CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: September 24, 2004
Result type: Reports
Project Number: S0022
Product Line: Common Drug Review

Generic Name: Adalimumab

Brand Name: Humira

Manufacturer: Abbott Laboratories Limited

Indications: Arthritis, Rheumatoid

Submission Type: New

Project Status: Complete

Date Recommendation Issued: February 11, 2005

Recommendation Type: List with clinical criteria and/or conditions